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I N T R O D U C T I O N
The voltage-gated sodium channels determine the ris-
ing phase of an action potential and the length of the 
refractory period in nerves, skeletal muscle, and heart 
(Catterall, 2000; Hille, 2001). Local anesthetics along 
with  antiarrhythmics  and  anticonvulsants  comprise  a 
group of compounds that are clinically one of the most 
important and widely used modifiers of sodium channel 
function (Fozzard et al., 2005). When used to treat   
peripheral pain, they simply block the pore of the   
sodium  channels  in  resting  state,  thereby  preventing 
further propagation of action potentials. On the other 
hand, the primary mode of action of anticonvulsants 
and antiarrhythmics is to block the sodium currents 
in a frequency-dependent manner (Strichartz, 1973). 
This phenomenon, termed as use-dependent block, makes 
the drug a more potent blocker when the sodium chan-
nels activate with a higher frequency. Thus, these “smart” 
compounds behave as low frequency filters in an elec-
trical circuit, attenuating uncontrolled high frequency 
activity associated with disease states such as arrhythmias 
and epilepsies.
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To account for these striking effects of local anesthetics 
on the sodium channel, it has been proposed that these 
drugs bind with a high affinity to the open/inactivated 
state relative to the closed state of the channel (Hille, 
1977). Alternatively, the guarded receptor hypothesis 
postulates that the binding site for the local anesthetic 
is gated and becomes accessible only when the channel 
opens (Strichartz, 1973; Starmer et al., 1984). Although 
both of these models can rationalize the basic phe-
nomenology, several lines of evidence suggest that the   
presence  of  a  local  anesthetic  profoundly  modifies 
the voltage-dependent gating behavior of the sodium   
channel. Gating current measurements show that the 
total  charge  associated  with  channel  activation  is  re-
duced in the presence of local anesthetics (Keynes and 
Rojas,  1974;  Peganov  and  Khodorov,  1977;  Cahalan, 
1978;  Cahalan  and  Almers,  1979;  Tanguy  and  Yeh,   
1989; Hanck et al., 1994; Sheets and Hanck, 2003).   
Fluorescence–voltage (F-V) curves of probes attached 
to domain III voltage sensor were shifted to more hyper-
polarized potentials upon the addition of lidocaine 
(Muroi and Chanda, 2009). Moreover, this modification 
of the voltage sensor is tightly linked to use-dependent 
block of sodium currents (Hanck et al., 2009; Muroi 
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The hallmark of many intracellular pore blockers such as tetra-alkylammonium compounds and local anesthetics 
is their ability to allosterically modify the movement of the voltage sensors in voltage-dependent ion channels. For 
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cantly altering use-dependent block at saturating drug concentrations. In the wild-type skeletal muscle sodium 
channel, local anesthetic block is accompanied by a 21% reduction in the total gating charge. In contrast, point 
mutations in this critical intracellular region reduce this charge modification by local anesthetics. Our analysis of 
a simple model suggests that these mutations in the gating interface are likely to disrupt the various coupling inter-
actions between the voltage sensor and the pore of the sodium channel. These findings provide a molecular   
framework for understanding the mechanisms underlying allosteric interactions between a drug-binding site and 
voltage sensors.
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M AT E R I A L S   A N D   M E T H O D S
Molecular biology and oocyte expression
All mutants were generated in the background of the mutant 
(L1115C) rat skeletal muscle sodium channel (rNav 1.4), as de-
scribed previously (Muroi et al., 2010). cDNAs of both  and  
subunit of rNav 1.4 were linearized with NotI digestion (New   
England  Biolabs,  Inc.)  and  transcribed  using  the  mMESSAGE 
mMACHINE T7 kit (Applied Biosystems). Equimolar ratios of   
 and  subunit mRNAs were coinjected into Xenopus laevis oocytes   
to a final volume of 50 nL. Oocytes were obtained from Nasco or 
surgically removed from Xenopus according to the guidelines of the 
Animal Care and Use Committee at the University of Wisconsin-
Madison. After injection, the oocytes were kept at 18°C in a solu-
tion containing (in mM): 100 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2,   
5 HEPES, 0.1 DTT, and 0.2 EDTA, supplemented with 100 µg/ml 
gentamicin  and  100  mg/ml  bovine  serum  albumin.  Measure-
ments were performed within 1–7 d after injection.
Fluorescence and electrophysiology measurements
The oocytes were incubated for labeling with 10 µM tetramethy-
rhodamine maleimide (TMRM; Invitrogen) in a depolarizing   
solution (in mM: 110 KCl, 1.5 MgCl2, 0.8 CaCl2, and 10 HEPES, 
pH 7.5) on ice for 30 min. 10 mM TMRM stock solution was pre-
pared  in  DMSO  and  stored  at  20°C.  Labeled  oocytes  were 
washed and stored at room temperature in 115 mM N-methyl glu-
camine (NMG) containing external solution until recording. All 
recordings were obtained at room temperature (22 ± 3°C). Fluor-
escence  recordings  were  performed  as  described  previously 
(Muroi and Chanda, 2009). In brief, the labeled oocytes were po-
sitioned in a modified cut-open oocyte setup (CA-1B; Dagan Cor-
poration)  and  placed  on  a  stage  of  an  upright  microscope 
(BX50WI; Olympus), and the current and fluorescence signals 
were simultaneously measured under voltage clamp conditions. 
The light from a xenon lamp source (Hamamatsu Photonics) was 
filtered with a 535/HQ50 bandpass filter and split using a Q565LP 
dichroic mirror (Chroma Technology Corp.). The emitted light 
was filtered with a 610/HQ75 bandpass filter and focused onto a 
PIN-020A photodiode (UDT Instruments) by a condenser lens. 
The photodiode was connected to the integrating headstage of a 
patch clamp amplifier (Axopatch 1B; Axon Instruments, Inc.). 
Gating current recordings were obtained using the cut-open   
oocyte technique. 10 µM tetrodotoxin (TTX) was first added to 
the external solution in the top and middle chambers, followed 
by lidocaine application. Measurements of use-dependent block 
were  obtained  using  the  two-electrode  voltage  clamp  setup   
(OC-725C Oocyte Clamp; Warner Instruments).
Recording solutions
Fluorescence and gating current recordings obtained in the pres-
ence of external solution (105 mM NMG-Mes, 20 mM HEPES, and 
2 mM Ca
2+, pH 7.4) and internal solution (105 mM NMG-Mes,   
20 mM HEPES, and 2 mM EGTA, pH 7.4) were used. Ionic current 
recordings were obtained in two-electrode voltage clamp setup, 
with an external solution composed of 21 mM NaMes, 84 mM 
NMG-Mes, 20 mM HEPES, and 2 mM Ca
2+, adjusted to pH 7.4.
Data acquisition and analysis
Analogue signals were sampled at 250 kHz with a Digidata 1440 
interface (MDS Analytical Technologies) and low-pass filtered at 
10 kHz. For gating current measurements, linear leak and mem-
brane capacitive current were subtracted online by a P/4 proce-
dure with a subtraction holding potential of +50 mV. Gating 
currents were obtained by applying a 20-ms test pulse to voltages 
ranging from 130 to +40 mV, with a pre- and post-pulse of 50 ms 
at 130 mV. The holding potential was 80 mV.
and  Chanda,  2009).  These  findings  suggest  that  the 
voltage sensor of domain III is stabilized in the activated 
state upon use-dependent block of sodium currents by 
local anesthetics. Structure–function studies implicate a 
cluster of residues in the S6 helices lining the central 
pore as the binding site primarily responsible for use-
dependent block (Ragsdale et al., 1994; Wang and 
Wang, 1998; Wright et al., 1998; Wang et al., 2000;   
Yarov-Yarovoy et al., 2001, 2002). Because the voltage-
sensing domain is likely to be a well-defined structural 
module separate from the pore domain (Long et al., 
2005, 2007), these findings suggest that local anesthetic 
binding to the pore allosterically modulates the voltage 
sensors of the sodium channel. Similar studies in the   
inactivation-removed Shaker potassium channel show 
that the OFF gating current is reduced in the presence 
of tetra-ethylammonium ions (Bezanilla et al., 1991). 
Thus, allosteric modification of voltage gating by pore 
blockers may be a common feature of the voltage- 
dependent ion channel superfamily.
To determine molecular pathway–mediating interac-
tion between the lidocaine-binding site and domain III 
voltage sensor of the sodium channel, we focused on 
the role of the intracellular gating interface. Studies in 
the Shaker potassium channel have identified two gat-
ing interfaces that are likely to be involved in electro-
mechanical  coupling  of  the  voltage  sensor  and  pore 
gates  (Schoppa  et  al.,  1992;  Smith-Maxwell  et  al., 
1998a,b; Ledwell and Aldrich, 1999; Hackos et al., 2002; 
Lu et al., 2002; Soler-Llavina et al., 2006; Lee et al., 
2009). Mutagenesis and domain swap experiments have 
shown that residues in the S4–S5 linker and the intra-
cellular end of S5 and S6 play a crucial role in coupling 
S6 segments to the voltage sensor movement. Lee et al. 
(2009) have suggested that the interface between S1 
and the neighboring S5 segment is also involved in elec-
tromechanical coupling. In this study, we systematically 
mutated residues in the S4–S5 linker and S5 and S6   
segments in domain III and examined the effect of   
lidocaine on the movement of this voltage sensor using 
voltage clamp fluorimetry and gating current measure-
ments. The binding of lidocaine to the wild-type (WT) 
skeletal muscle sodium channel shifts the midpoints of the 
activation curves of domain III voltage sensor by >50 mV 
in the hyperpolarizing direction. We identify a set of 
residues that when mutated to a tryptophan dramati-
cally reduce the effect of lidocaine on the steady-state 
properties of domain III voltage sensor. Measurements 
of gating currents show that lidocaine block of sodium 
currents in these mutants has a much smaller effect on 
the total gating charge modification compared with   
the WT sodium channels. Moreover, the maximal use- 
dependent block of the mutants is comparable to the WT 
channels. These findings suggest that the intracellular 
gating interface is a major pathway for allosteric modu-
lation of voltage sensor movement by local anesthetics.  Arcisio-Miranda et al. 543
the voltage sensor (with bound lidocaine), zR, as: zR = zV. The 
binding affinity (or association constant) of lidocaine, KA (which 
is the product of the equilibrium binding constant and the con-
centration of lidocaine), and the coupling parameter  are con-
sidered to be voltage independent.
For the first run of the fitting, the initial guesses of the different 
parameters were taken from our previous study (Muroi et al., 
2010), and a set of optimized parameters was obtained. The ro-
bustness of the fit was checked by repeating the fitting procedure 
1,000 times. For every iteration, six random numbers between 
10
2 and 10
2 were generated. Each of the six parameters, obtained 
from the first run, was scaled separately by the random numbers. 
The rescaled parameter values were used as the initial estimates 
to repeat the fitting procedure. Thus, this random sampling algo-
rithm allows us to efficiently search a six-dimensional parameter 
space spanning over four orders of magnitude and generate a 
probability distribution of the optimized value for each parame-
ter. The mean and the percent standard deviation for the opti-
mized parameters are reported in Table II. This fitting procedure 
was performed on the WT data and on one of the high impact 
mutants (A1145W). The simulated F-V traces are shown in Fig. 6.
Online supplemental material
Fig. S1 shows a sequence alignment of the four domains of the 
rNav 1.4 channel with Kv1.2/2.1 chimera and KcsA channel. 
Thermodynamic relationships between obligatory and nonoblig-
atory coupling models are described in the supplemental text.   
Parameters obtained by fitting F-V curves to a Boltzmann func-
tion are shown in Table S1. The supplemental material is available 
at http://www.jgp.org/cgi/content/full/jgp.201010438/DC1.
R E S U LT S
Mutations in the cytoplasmic gating interface alter  
the drug-induced shift in voltage sensor movement
The tryptophan-scanning mutagenesis was performed 
in the intracellular gating interface of domain III of the 
sodium channel (Fig. 1). This interface was formed in 
part by the S4–S5 linker region and the intracellular 
ends of the S5 and S6 transmembrane segments. The 
effect of these mutations on allosteric coupling was as-
sessed  by  attaching  a  fluorophore,  tetramethylrhoda-
mine, near the extracellular end of the S4 segment of 
domain III and monitoring the changes in fluorescence 
intensity in response to lidocaine block of ionic currents. 
Previous studies have shown that the voltage-dependent 
fluorescence intensity changes from a probe on Leu1115 
position in the muscle sodium channel correlate with its 
gating charge movement and are likely to be reporters 
of  voltage-dependent  conformational  changes  associ-
ated with the S4 of domain III movement (Chanda and 
Bezanilla, 2002).
55 mutants were generated in the background of the 
L1115C mutant sodium channel. This L1115C mutant 
is hereafter referred to as the WT channel. Most muta-
tions were tryptophan substitutions, which because of 
their large side chain volume are likely to disrupt the 
tight packing at the interfaces. When, in some instances, 
tryptophan substitutions resulted in nonfunctional pro-
tein or low expression, alanine was substituted. The effect 
Each fluorescence trace represents an average of 10 recordings 
obtained by a 20-ms test pulse from 120 mV after a 20-ms condi-
tioning pulse at 10 mV, with a holding potential of 80 mV. The 
interval between the conditioning and test pulse was 100 ms. The 
conditioning pulse was used to ensure that the channel was fully 
blocked by lidocaine. Fluorescence intensity decay from photo-
bleaching was corrected by fitting the trace to a single exponen-
tial or a straight line and subtracting it from the original trace. 
The data were subsequently low-pass filtered offline at 5 kHz.
F-V and gating charge–voltage (Q-V) curves were fitted to a single 
Boltzmann function:
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where z is the apparent valence, e is the electronic charge, V1/2 is 
the half-maximal voltage, K is the Boltzmann constant, and T is 
the temperature.
To measure use-dependent block, 100 test pulses of 20 ms at 
20 mV (10 Hz) from a holding potential of 80 mV were   
applied. The pulsing frequency was varied to measure frequency-
dependent block. All data were acquired using Clampex (MDS 
Analytical Technologies) and analyzed with Clampfit, Excel (Micro-
soft), or Origin (GE Healthcare). Prism (GraphPad Software) was 
used for statistical analysis.
Homology modeling
The homology models of the sodium channel in the open state 
were developed using the crystal structure of the KV1.2/2.1 chimera 
(Protein Data Bank accession no. 2R9R) as a template. The se-
quences  of  the  putative  sodium  channel  domains  were  first 
aligned to the template sequences using ClustalW (Thompson   
et al., 1994), with default alignment parameters. The alignment 
was manually optimized to minimize the gaps within the putative 
transmembrane segments of the different sequences (Fig. S1). 
The homology modeling was performed using Modeller 9v4 (Sali 
and Blundell, 1993). 100 candidate models (S1 through S6) were 
generated for each of the four domains of the sodium channel. 
The final model for each domain was selected on the basis of the 
DOPE (discrete optimized potential energy) scores and the ste-
reochemical quality of the candidate models, as assessed from the 
Ramachandran plots. The models of the four domains were orga-
nized symmetrically around the axis of K
+ conduction by using an 
appropriate transformation of coordinates to generate the final 
tetrameric  structure.  To  remove  certain  bad  contacts/steric 
clashes, especially in the membrane reentrant loop (pore helix) 
between S5 and S6, it was necessary to move each of the four   
domains radially outward (by 1.5 Å). In vacuo energy minimiza-
tion of this tetrameric structure was performed using NAMD 2.6 
(Phillips et al., 2005), with the CHARMM 27 force field parame-
ters and with all atomic charges switched off.
Modeling state occupancies
The expressions for the probability of the voltage sensor activa-
tion in the absence and presence of lidocaine, as derived from 
Scheme 2 (Eqs. 1 and 2), were fitted to the corresponding F-V 
data. The data fitting of both equations was performed simultane-
ously, so that one dataset served as a constraint for the other.   
Fitting was performed using the MATLAB curve-fitting toolbox 
(robust  nonlinear  least-squares  method,  Levenberg-Marquardt 
algorithm) to obtain the values of the different thermodynamic 
parameters. The parameters KV, KP, and KR are all voltage-dependent 
equilibrium constants, and their voltage dependence can be ex-
pressed as  K K z FV i i i =
0 exp ( ),   β  where i = V, P, or R. The voltage 
dependence of activation of the voltage sensor (with unbound li-
docaine), zV, is related to that of the deactivation (or return) of 544 Allosteric modification of sodium channels by local anesthetics
and a majority of those are in the S4–S5 linker and S6 
segment of domain III. The mutants that produce a 
<20-mV hyperpolarizing shift in V1/2 in the presence of 
lidocaine  were  designated  as  high  impact  mutants, 
whereas those that produce shifts >20 mV but <55 mV 
were designated as low impact mutants. Fig. 2 C shows 
that only seven (R1135W, V1142W, A1145W, S1276W, 
I1284W, I1287W, and K1295W) out of the 55 tested in 
this study show a <20-mV hyperpolarizing shift in the 
V1/2 in the presence of lidocaine. Mutations in 17 other 
sites were designated as low impact mutants.
Mutations in the gating interface alleviate gating charge 
modification by lidocaine
Gating charge studies show that local anesthetic block 
of sodium currents is accompanied by a 21% reduction 
in the total gating charge (Hanck et al., 1994; Sheets 
and Hanck, 2007; Muroi and Chanda, 2009) (Fig. 3 A). 
If a tryptophan mutation disrupts the interaction between 
local anesthetic-binding site and domain III voltage sen-
sor, we would predict that the extent of charge modifi-
cation by lidocaine will be diminished. This hypothesis 
was tested by measuring charge modification by lido-
caine in six of the seven high impact mutants identified 
by  fluorescence  measurements.  Use-dependent  block 
of these mutations on the conductance–voltage relation-
ships and voltage-dependent fluorescence of domain III 
has been characterized in a recent study (Muroi et al., 
2010). Fig. 2 A shows a comparison of representative 
voltage-dependent  fluorescence  traces  before  and   
after  the  addition  of  lidocaine  in  the  WT  and  two   
mutants (A1145W and I1287W). Normalized F-V rela-
tionships were obtained by plotting the fluorescence 
intensities near the end of a 20-ms depolarizing pulse 
with respect to the membrane potential. 10 mM lido-
caine in the bath ensures complete block of WT and 
mutant channels. To quantitatively assess the effect of 
these  mutations,  the  data  were  fitted  to  a  single 
Boltzmann function, and the values of the two parame-
ters, the slope (z), and the voltage-eliciting half-maxi-
mal response (V1/2) were obtained. In the WT channel, 
the addition of lidocaine causes a dramatic shift in the 
F-V curve, such that the V1/2 is shifted to a more hyper-
polarized potential by 56.1 mV (Fig. 2 B, left). Fig. 2 B 
(middle and right) shows two representative tryptophan 
mutants, A1145W and I1287W, where the drug-induced 
shifts of F-V curves by lidocaine were reduced. The   
effect of lidocaine on the F-V curves for all the mutants 
is summarized in Fig. 2 C and Table S1. Approximately 
half of the mutants show significantly reduced F-V shifts, 
Figure 1.  Sequence alignment of the putative transmembrane segments of domain III of the brain, nerve, and the muscle sodium chan-
nels (Nav1.2, Nav1.4, and Nav1.5) with a chimeric potassium channel (Kv1.2/2.1). The conserved positive charges of the S4 transmem-
brane segment are highlighted in green. The mutated regions in the S4–S5 linker, N terminus of S5, and C terminus of S6 are shown in 
red. The fluorophore was attached to an introduced cysteine at the L1115C (in orange) position.
TA B l e   I
Effect of 10 mM lidocaine on the gating current properties of WT and mutant channels
Channel Control (TTX) Lidocaine (+TTX) Remaining gating charge
n V1/2 z V1/2 z %
WT 6 63.8 ± 2.4 1.34 ± 0.02 63.3 ± 1.9 1.45 ± 0.03 79.0 ± 3.8
R1135W 4 65.9 ± 1.9 1.38 ± 0.06 63.8 ± 0.8 1.38 ± 0.06 91.4 ± 3.7
V1142W 4 50.4 ± 2.9 1.01 ± 0.06 57.6 ± 0.9 1.19 ± 0.03 90.0 ± 2.5
A1145W 3 56.0 ± 2.3 1.00 ± 0.03 54.3 ± 4.3 1.11 ± 0.03 96.2 ± 1.7
I1284W 3 57.3 ± 2.8 1.30 ± 0.11 54.2 ± 5.7 1.20 ± 0.00 100.0 ± 2.2
I1287W 3 55.0 ± 1.2 1.13 ± 0.03 59.2 ± 1.5 1.33 ± 0.01 92.0 ± 3.6
K1295W 4 53.7 ± 3.3 0.93 ± 0.01 59.2 ± 5.1 1.08 ± 0.02 91.2 ± 2.4
Boltzmann parameters from a first-order fit of the Q-V relationships. All measurements were done in the presence of TTX. Data represent the mean ± SEM 
of at least three independent experiments (n).  Arcisio-Miranda et al. 545
Fig. 3 C, and the parameters for Boltzmann fits of the 
Q-V curves are in Table I. In the WT skeletal muscle   
sodium channel, lidocaine does not significantly alter 
the midpoints and the slope of the Q-V relationships, 
but reduces the maximum gating charge moved in re-
sponse to large depolarization. The introduction of a 
tryptophan in the six high impact sites significantly   
in  S1276W  mutant  was  found  to  be  highly  impaired 
(data shown in the next section); therefore, gating cur-
rents for this mutant were not assessed. The Q-V rela-
tionships of six high impact mutants before and after 
the addition of 10 mM lidocaine are shown in Fig. 3 B. 
The effect of lidocaine on total gating charge in the mu-
tant channels as compared with WT is summarized in 
Figure 2.  Effect of lidocaine on the energetics of the domain III voltage sensor. (A) Time course of voltage-dependent fluorescence 
signals from domain III of WT and a couple of representative mutant sodium channels. Fluorescence traces were obtained before and 
after 10-mM lidocaine application by pulsing to a test potential (ranging from +50 to 210 mV) for 20 ms, with a prepulse to 120 mV 
for 20 ms. Each trace represents an average of 10 trials with an interval of 1 s between each pulse. The scale bars are provided as insets, 
and the percentage fluorescence changes (F/F) are on the y axis. (B) Steady-state F-V curves before (filled symbols) and after (open 
symbols) 10-mM lidocaine application. The lines represent the best fits of the averaged data to a single Boltzmann function. The error 
bars represent the average ± SEM for each data point. (C) Summary of shifts in F-V curves of WT and various mutants upon the appli-
cation of lidocaine. V1/2 was obtained as: V1/2 = V1/2(after lidocaine)  V1/2(before lidocaine). Each bar represents mean ± SEM of at least three 
independent oocyte measurements. The gray dashed line represents the shift in F-V curves of WT. To test whether these differences were 
statistically significant, a one-way ANOVA test was used, followed by a post-hoc Dunnett’s test. *, P < 0.001; #, P < 0.05.546 Allosteric modification of sodium channels by local anesthetics
Figure 3.  Effect of lidocaine on gating currents of WT and mutant sodium channels. (A; left) Representative ON gating currents   
of the WT channels and their integrals before and after 10-mM lidocaine application. (Right) Steady-state Q-V relationships of the   
WT channel before (filled symbols) and after (open symbols) lidocaine application. The gray dashed line represents the average   
reduction in the total gating charge after lidocaine application. The data represent mean ± SEM of at least three independent mea-
surements. The line represents the best fit of the averaged data to a single Boltzmann function. (B) Steady-state Q-V relationships 
of mutant channels before (filled symbols) and after (open symbols) 10-mM lidocaine application. The gray dashed line represents   
the average reduction in the total gating charge after the application of lidocaine to the WT channel. The data represent mean ± SEM   
of at least three independent measurements, and the smooth lines represent the best fits of the averaged data to a single Boltzmann 
function. (C) Percentage reduction in the total gating charge upon the application of lidocaine in the WT and mutant channels.   
The total charge movement was measured by a pulse to +40 mV from 130 mV. The data represent mean ± SEM of at least three inde-
pendent measurements.  Arcisio-Miranda et al. 547
sodium channel (Wang et al., 2004). Use-dependent block 
for both high and low impact mutants was obtained in the 
presence of 1 mM lidocaine because the fluorescence 
and gating charge measurements were recorded under 
saturating conditions of lidocaine (Fig. 4 C). At this con-
centration of lidocaine, 70% of the WT sodium chan-
nels are blocked in a use-dependent manner. Most 
mutants exhibit similar use-dependent block, which 
suggests that the loss of voltage sensor modification is 
not because of their inability to bind to lidocaine. Only 
4 out of the 25 show a significantly lower use-dependent 
block at these drug concentrations. The most dramatic 
effect was observed upon mutation of the Ser at posi-
tion 1276, resulting in a significantly diminished use- 
dependent  block  of  sodium  currents.  This  mutant 
also exhibits a much smaller shift of F-V curve upon   
lidocaine addition (V1/2 = 20 mV) relative to the WT 
channels. These findings are consistent with other stud-
ies showing that the Serine1276 in the skeletal muscle 
sodium  channel  is  critical  for  use-dependent  block 
(Wang et al., 2000).
Next, we examine the correlation between lidocaine-
induced shifts of F-V curves and maximal use-dependent 
block  (Fig.  5).  For  mutants  A1149W  and  S1276W,   
reduces this gating charge modification by lidocaine.   
In the case of two of the mutants, A1145W and I1284W, the 
addition of lidocaine has almost no effect on gating charge 
movement. These findings indicate that mutations in key 
positions corresponding to the high impact sites in the 
cytoplasmic gating interface disrupt the interaction   
between the voltage sensor and the lidocaine-binding site.
Effect of mutations on use-dependent block by lidocaine
Previous studies have shown that the ability of lidocaine 
to block sodium currents in a use-dependent manner 
was  essential  for  modification  of  the  voltage  sensor 
movement  (Hanck  et  al.,  2009;  Muroi  and  Chanda, 
2009).  Here,  we  test  whether  lidocaine  at  saturating 
concentrations can inhibit the mutant sodium currents 
in a use-dependent manner. Fig. 4 A shows a family of 
WT sodium current traces elicited by applying 100 de-
polarizing pulses to 20 mV from a holding potential 
of 80 mV (10-Hz frequency) in the presence of lidocaine. 
To  obtain  a  dose–response  curve  for  use-dependent 
block, the peak sodium current at the 100th pulse is 
plotted with respect to lidocaine concentration (Fig. 4 B). 
The estimated IC50 for the L1115C mutant skeletal mus-
cle sodium channel is 20 µM, a value similar to the WT 
Figure 4.  Use-dependent block of WT and mutant channels by lidocaine. (A) Representative ionic current traces of WT channel in 
the presence of different concentrations of lidocaine. Each trace was obtained by applying 100 pulses from 80 to 20 mV for 20 ms at   
10 Hz from a holding potential of 80 mV. (B) Dose–response curve for use-dependent block of WT channel by lidocaine. The symbols 
represent mean ± SEM of at least three independent measurements, and the smooth line represents the best fit of the averaged data 
to the Hill equation. (C) Percent block of WT and mutant channels after 100 pulses in presence of 1 mM lidocaine. Gray dashed line 
represents the mean percent block of the WT channel (71.5 ± 2.2%; n = 5). The current protocol is the same as in A. In both B and C, 
the data represent mean ± SEM of at least three independent measurements.548 Allosteric modification of sodium channels by local anesthetics
is relatively well established (Sheets and Hanck, 2003, 
2007; Muroi and Chanda, 2009), its effect on the pore 
structure remains controversial. It has been suggested 
by several groups that lidocaine stabilizes the channel 
use-dependent block at 1 mM lidocaine concentration 
is much smaller than that of the WT. Furthermore, fluor-
escence shift induced by lidocaine is also reduced com-
pared to WT. A simple interpretation is that mutations 
at these positions alter use-dependent block, such that a 
smaller fraction of the channels compared to the WT is 
modified. The ionic currents of the other six high impact 
mutants, in contrast, were blocked in a use-dependent 
manner, like the WT channels as shown in Fig. 5 (filled 
circles). Thus, in these mutants the lidocaine block of 
the sodium currents appears to be largely decoupled 
from domain III voltage sensor modification. The ma-
jority of the low impact mutants show relatively intact 
use-dependent block but varying degree of lidocaine-
induced shifts in F-V curves, suggesting that voltage   
sensor modification in these mutants is at least partially 
decoupled from lidocaine binding.
D I S C U S S I O N
Many intracellular pore blockers allosterically modify 
the movement of the voltage-sensing charges in voltage-
dependent  ion  channels.  High  resolution  structural 
and functional studies of K
+ and Na
+ channels support 
the emerging view that S4 motions are transmitted 
through  a  gating  interface  encompassing  the  S4–S5 
linker and the cytoplasmic ends of S5 and S6 helices 
(Lu et al., 2002; Long et al., 2005; Soler-Llavina et al., 
2006; Lee et al., 2009; Muroi et al., 2010). The motiva-
tion for the present study is to investigate the role of this 
gating interface in coupling the conformation of the   
lidocaine-binding site to the movement of the voltage 
sensor in a sodium channel.
Although the notion that lidocaine binding to the   
sodium channel stabilizes the activated voltage sensor 
Figure  5.  Relationship  between  the  V1/2  of  F-V  curves  and 
maximal use-dependent block by lidocaine. V1/2 of F-V curves 
upon lidocaine addition and the maximal use-dependent block 
of ionic currents by lidocaine were obtained as described in the 
Results. The mutants whose V1/2 shifts linearly correlate with 
use-dependent block are represented as open squares. The mu-
tants that show the most reduction in V1/2 without much change 
in use-dependent block are represented by filled circles, and the 
remaining mutants that show intermediate levels of reduction in 
the V1/2 are represented by open symbols.
Figure 6.  Simulations of fluorescence activation curves of WT and a mutant before and after the addition of lidocaine. The equations 
describing the probability of activation of the voltage sensor were fitted to the WT data (A) and A1145W (B) to generate the activation 
curves shown above (refer to Materials and methods). Symbols represent the simulated data points, and the trend lines are fits of the 
simulated data with a single Boltzmann function.  Arcisio-Miranda et al. 549
   
(SCHEME 1a)
To consider the effects of local anesthetic on voltage 
sensor activation, we extend our initial scheme to include 
two new lidocaine-bound states: VAPO
L and VRPO
L. We 
assume that the lidocaine binds to the open pore (i.e., 
in channel states VRPO and VAPO), as suggested by studies 
on inactivation-deficient sodium channels (Wang et al., 
2004) and quaternary ammonium (Armstrong, 1971). 
Studies in inactivation-deficient channels show that   
lidocaine-binding affinity is similar to the WT channels. 
For  simplicity,  we  ignore  the  presence  of  inactivated 
states and lidocaine binding to the inactivated states. 
The addition of lidocaine modifies the above system, 
which is now described by Scheme 1b, where KA is the 
association constant of lidocaine with the open pore.
   
(SCHEME 1b)
Studies on voltage-gated potassium channels suggest 
that the equilibrium constant for spontaneous opening 
of the pore is very low and, therefore, the state VRPO is 
in the inactivated state (Scheuer, 1999). The affinity 
of  the  lidocaine  to  the  inactivated  cardiac  sodium 
channel was estimated to be 10 µM, comparable to its 
therapeutic working concentration (Bean et al., 1983). 
The  removal  of  inactivation  in  the  squid  sodium 
channels by pronase abolished use-dependent block 
by  QX-314,  suggesting  that  the  local  anesthetics   
bind  mainly  to  the  inactivated  channels  (Cahalan, 
1978; Yeh, 1978). In contrast to these findings, Wang 
et al. (1987) reported that QX-314 retains its potency 
on  inactivation-deficient  sodium  currents  obtained 
by treatment with chloramine-T. Cysteine accessibility 
studies show that the use-dependent block does not 
involve accumulation of the fast inactivated channels 
(Vedantham and Cannon, 1999). Moreover, in another 
inactivation-deficient mutant sodium channel, the IC50 
for lidocaine block was found to be comparable to 
those of the WT channels (Wang et al., 2004). Collec-
tively, these findings suggest that the lidocaine may 
modulate  the  transitions  that  are  associated  with 
channel opening, rather than those leading to inacti-
vated states.
Thermodynamic implications of mutations that disrupt 
allosteric modification
Next, we consider a simple qualitative model of an ion 
channel  consisting  of  a  voltage  sensor  and  a  pore, 
each of which can exist in two possible states (Scheme 
1a).  This  system  exists  in  four  possible  states:  VRPC 
(pore closed and voltage sensor resting), VRPO (volt-
age  sensor  resting  and  pore  open),  VAPC  (activated 
voltage sensor and closed pore), and VAPO (activated 
voltage sensor and open pore). This model can be de-
scribed by three thermodynamic parameters: K1 is the 
intrinsic activation constant of the voltage sensor, K2 is 
the  intrinsic  activation  constant  of  the  pore,  and   
represents the interaction between the activated volt-
age sensor and open pore. For the purposes of this 
analysis, we ignore the cross interaction terms as well 
as the interaction between the resting voltage sensor 
and closed pore.
TA B l e   I I
Parameters obtained from fitting Scheme 2 to the F-V data
Construct KV
0 ZV KP
0 ZP KA KR
WT 15.2 (4.3) 1.5 (3.7) 5.8 (1.7) 0.36 (4.5) 953.3 (0.9) 0.00046 (6.9)
A1145W 32.9 (1.8) 1.18 (2.5) 0.13 (5.6) 0.22 (5.9) 968.7 (1.4) 0.018 (5.8)
K1
0 Z1 K2
0 Z2 KA 
WT 15.2 1.5 0.041 0.36 953.3 143
A1145W 32.9 1.18 0.076 0.22 968.7 1.7
The values of the parameters of Scheme 2, reported here, are the mean of the parameter values obtained from the 1,000 fitting procedures (refer to 
Materials and methods). The standard deviation, expressed as a percentage of the mean, of each parameter is reported in parentheses. From the fitted 
values of KV, KP, and KR, the intrinsic parameters  K1
0
,  K2
0
, and  were derived using the relations provided in Eq. 3.550 Allosteric modification of sodium channels by local anesthetics
Examination of the above relationships shows that 
the equilibrium constant for VRPC to VAPC transition is 
K1, whereas that for the VRPO
L to VAPO
L transition is 
K1. Because the voltage sensor and pore are positively 
coupled to each other ( greater than 1), the activa-
tion of the voltage sensor is always favored in the pres-
ence of lidocaine. This analysis also shows that when   
 tends to 1, the transitions VRPC to VAPC and VRPO
L to 
VAPO
L will become energetically identical. Under these 
conditions, the binding of lidocaine to the pore is going 
to have small or no effects on the movement of the 
voltage sensor.
The equations governing the probability of activa-
tion of the voltage sensor in the absence and pres-
ence of lidocaine (Eqs. 1 and 2) were fitted to the F-V 
traces of one of the high impact mutants, A1145W 
(Fig. 6 B). Examination of the fitted parameters for 
the mutant (Table II) shows that this mutation mostly 
affects the KR and KP terms. Expressing the KR and KP 
in terms of K1, K2, and  (using Eq. 3) reveals that this 
interaction term is reduced by 80-fold in the A1145W 
mutant. This large change in coupling term accounts 
for most of the reduction in the lidocaine-induced 
shifts of F-V curves in mutant channels. We note that 
although the Monte Carlo–like-fitting algorithm effi-
ciently  samples  a  larger  parameter  space  (varying 
over four orders of magnitude), we cannot eliminate 
the possibility that the equilibrium values reported in 
Table II are just one set of values that describe our 
data. Therefore, we cannot completely rule out other 
mechanisms to explain the lidocaine-induced fluor-
escence changes.
By examining the effect of these mutations on the 
probabilities of voltage sensor and pore opening in 
the absence of lidocaine, we can also make inferences 
regarding the thermodynamic effects of these muta-
tions.  The  above  analysis  shows  that  the  mutations 
where the interaction between activated voltage sen-
sor and open pore is disrupted would exhibit small 
shifts in the F-V upon the addition of lidocaine. This 
would also cause rightward shifts in the F-V and G-V 
curves  of  this  mutant  in  the  absence  of  lidocaine, 
which was observed for the V1142W mutant (Muroi 
et al., 2010). A similar loss of coupling interactions 
between the resting-state voltage sensor and closed 
pore can account for small shifts in F-V curves upon 
lidocaine application (supplemental text). Three of 
the high impact mutants at I1284, I1287, and K1295 
cause  a  leftward  shift  in  the  activation  probability 
curves of the voltage sensor and pore opening, which 
suggests that these mutations disrupt the resting-state 
interactions  between  the  voltage  sensor  and  pore. 
The remaining two mutants, R1135W and A1145W, 
both cause opposite effects on the activation proba-
bilities of the voltage sensor and pore. In these mu-
tants, the closed state of the pore is stabilized while 
sparsely populated (Hoshi et al., 1994). Therefore, 
Schemes 1a and 1b can be rewritten as a sequential 
model depicted in Schemes 2a and 2b.
   
(SCHEME 2a)
   
(SCHEME 2b)
The probabilities of activation of the voltage sensor, as 
derived from Scheme 2, with and without lidocaine are:
  P unbound
K K K
K K K
VA
V V P
V V P
      ( ) =
+
+ + 1
   (1)
     (2)
P bound
K K K K K K
K K K K K K K K K K
VA
V V P V P A
V V P V P A V P A R
      ( ) =
+ +
+ + + + 1
 
To determine the values of thermodynamic parame-
ters described in Scheme 2, the equations for the prob-
ability of activation of the voltage sensor (Eqs. 1 and 2) 
were fitted to the WT F-V curve before and after the ad-
dition of lidocaine. The parameters that provide a rea-
sonable fit to the WT data under both conditions are 
shown in Table II, and the simulated F-V curve of the 
WT is shown in Fig. 6 A.
Why does lidocaine binding cause a shift in the F-V 
curve? A comparison of Schemes 2a and 2b reveals 
that in the absence of lidocaine, the F-V curves reflect 
the transition between VRPC to VAPC. Saturating con-
centrations of lidocaine drive the equilibrium right-
wards, and the system transits primarily between two 
possible states: VRPO
L and VAPO
L. Under these condi-
tions,  the  F-V  curves  primarily  track  the  transition   
between the states VRPO
L and VAPO
L. To understand 
the thermodynamic implication of this shift, we can 
see that the general model (Scheme 1) can be reduced to 
the sequential model when VRPO has negligible contribu-
tion (see supplemental text). Thus, the thermodynamic 
parameters in Scheme 2 are related to Scheme 1 as:
  K K V = 1    (3a)
  K K P = θ  2    (3b)
  K K A A =    (3c)
  K K R =1 1 /θ     (3d)  Arcisio-Miranda et al. 551
pore with a very different structure, but primarily al-
ters the energetics associated with pore opening and 
closing transition.
Mapping the mutations on a structural model of the 
sodium channel
The positions of the decoupling mutants were mapped 
onto a surface representation of a homology model of 
Nav1.4 (Fig. 7, A and B) and the isolated domain III 
(Fig. 7, C and D). The residues were color-coded based 
on the degree of shift in the domain III voltage sensor 
activation upon drug application. These mutants were 
mostly  localized  in  the  S4–S5  linker  region  and  the 
lower end of the S6 segment. In the S4–S5 linker, they 
were exclusively limited to one face of the helix, indicat-
ing that this face plays a key role in coupling drug bind-
ing to voltage sensor activation. In contrast, such a clear 
pattern was not obvious in the S6 helix. Almost every 
residue in the stretch between L1282 to K1295 reduces 
the shifts in the domain III voltage sensor to a varying 
extent. One possibility is that the S6 helix, being in a 
tightly packed region near the bundle crossing, is likely 
the voltage sensor is stabilized in the activated state. 
The effects of these mutants are consistent with the 
idea that these mutations disrupt resting-state and ac-
tivated-state interactions (Muroi et al., 2010).
In sum, our analysis suggests that the mutations that 
disrupt  coupling  interactions  between  the  voltage   
sensor and pore would reduce the lidocaine-induced 
shift in F-V curves. All sites identified by Muroi et al. 
(2010) except the S1134W cause reduced shifts in the 
F-V curves upon the addition of lidocaine. Moreover, 
only the residues that contribute both to the resting-
state and activated-state interactions were identified in 
that study. By examining the effect of lidocaine on the 
mutations at the domain III intracellular gating inter-
face, we are able to identify a larger set of residues that 
are important for voltage sensor and pore coupling. 
More specifically, this study also identifies the residues 
that mainly contribute to resting-state interactions and 
those that are involved in the activated-state interac-
tions. Nonetheless, this interpretation should be con-
sidered tentative because it is based on the premise 
that  lidocaine  binding  does  not  produce  a  channel 
Figure 7.  Mapping the mutations that perturb allosteric modification by lidocaine. (A) Surface representation of the Nav1.4 sodium 
channel model with mutations that disrupt the communication between the lidocaine-binding site and voltage sensor, viewed from the 
intracellular side. A color gradient from yellow to red was used to represent V1/2 changes induced upon the addition of lidocaine.   
(B) Same as in A after the structure was rotated by 90°. The domains I and IV are hidden from view by the other two domains. (C) Surface 
representation of domain III of the Nav1.4 channel. The other three domains were removed for clarity. The residues were color-coded as 
in A. (D) A close-up view of the S4–S5 linker, N terminus of S5, and C terminus of S6, with transparent surfaces and side chains colored 
as in A. All of these structures were drawn using PyMol (DeLano Scientific LLC).552 Allosteric modification of sodium channels by local anesthetics
Chanda, 2009). This imposes an energetic cost on the 
return of the domain III S6 segment to a closed posi-
tion when the membrane is repolarized. This destabili-
zation of the closed pore by lidocaine binding would 
propagate  to  the  domain  III  voltage  sensor  because 
they are coupled. Therefore, lidocaine binding would 
shift the voltage-dependent activation of the domain 
III voltage sensor to more hyperpolarized potentials. 
Our finding that a strong hyperpolarization can drive 
the voltage sensor to a resting-state conformation sug-
gests that either the pore gates are able to close even 
when the lidocaine is bound to the channel, or that an 
intermediate state corresponding to a resting domain III 
voltage sensor and S6 domain III in an open conforma-
tion is populated. At present, we are unable to clearly 
distinguish between these two possibilities because of a 
lack of a conformational probe for tracking the dynam-
ics of individual pore segments. Despite these limita-
tions,  our  study  provides  strong  evidence  that  the 
intracellular gating interface is a major pathway for al-
losteric  coupling  between  the  drug-binding  site  and 
the voltage-sensing domains.
to interact promiscuously with the neighboring S6 seg-
ments in addition to its own S5 helix and S4–S5 linker. 
The introduction of tryptophan into this region causes 
a leftward shift in the F-V and G-V curves (Muroi et al., 
2010) in almost all the positions, consistent with the in-
terpretation that these residues disrupt interactions   
between the voltage sensor and the pore in the rest-
ing state. Scanning mutagenesis studies in potassium   
channels show that most mutations in the S6 region near 
the bundle crossing stabilize the open pore, presumably 
by disrupting the packing in the closed state (Yifrach 
and MacKinnon, 2002; Wynia-Smith et al., 2008).
Preliminary model of allosteric modulation
Finally, we consider a working model to rationalize the 
modification of voltage-dependent gating by intracel-
lular pore blockers (Fig. 8). The main assumption is 
that lidocaine-like quaternary ammonium compounds 
upon binding to the sodium channel prevent the pore 
from fully closing (Armstrong, 1971). Furthermore, we 
have  shown  recently  that  lidocaine  has  the  largest   
effect on the S6 segment of domain III (Muroi and 
Figure 8.  Plausible model for voltage sensor modification by local anesthetics. Upon depolarization, the voltage sensors move outward 
and the pore of the sodium channel opens. For clarity, only domains I and III are shown. Lidocaine binds to the open pore with high   
affinity (open lidocaine bound). When the membrane is repolarized, the domain III pore helices are unable to close because of lido-
caine occupying the binding site and destabilizing the resting state of the domain III voltage sensor relative to the open state. Strong hyper-
polarization drives the domain III voltage sensor to a resting-like conformation, even though the lidocaine-binding site is occupied.  Arcisio-Miranda et al. 553
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